Abstract
Experiments on male hybrid mice demonstrated that specific immunotherapy with preparations based on carcinoembryonal antigen and mucin containing CA 125 antigen was not associated with general toxicity, local irritating effect, and hepatorenal dysfunction. The absence of toxicity is apparently due to the fact that antigens injected intramuscularly or subcutaneously virtually do not enter the blood. Injections of preparations based on carcinoembryonal antigen and mucin containing CA 125 antigen to mice induced a standard immune response with predominance of class M immunoglobulins during the early terms and class G immunoglobulins at later terms.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
J. W. Hodge,Cancer Immunol. Immunother.,43, 127–134 (1996).
J. Kantor, K. Irvine, S. Abrams, et al.,Cancer Res.,52, No. 24, 6917–6925.
Author information
Authors and Affiliations
Additional information
Translated fromByulleten' Eksperimental'noi Biologii i Meditsiny, Vol. 129, No. 4, pp. 462–464, April, 2000
Rights and permissions
About this article
Cite this article
Sitdikova, S.M., Amandzholov, B.S., Sel'chuk, V.Y. et al. Immunotoxicological characteristics of preparations based on carcinoembryonic antigen and mucin containing CA 125 antigen. Bull Exp Biol Med 129, 389–391 (2000). https://doi.org/10.1007/BF02439280
Received:
Issue Date:
DOI: https://doi.org/10.1007/BF02439280